Elizabeth Glaser Pediatric AIDS Foundation

Last updated
Elizabeth Glaser Pediatric AIDS Foundation
Founded1988
Founder Elizabeth Glaser, Susie Zeegen, Susan DeLaurentis
Type Operating public charity
(IRS exemption status): 501(c)(3) [1]
Location
Key people
Charles Lyons (President & CEO)
Dr. David Kessler, M.D. (Chairman of the Board)
Revenue (2014)
$126,056,619 [2]
Expenses (2014)$126,187,776 [2]
Website www.pedaids.org

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is a nonprofit organization dedicated to preventing pediatric HIV infection and eliminating pediatric AIDS through research, advocacy, and prevention and treatment programs. [3] Founded in 1988, [4] the organization works in 12 countries around the world.

Contents

History

Background

Elizabeth Glaser (née Elizabeth Meyer) (November 11, 1947 – December 3, 1994) was an American AIDS activist and child advocate. She was married to actor and director Paul Michael Glaser. Glaser contracted HIV in 1981 during the early stages of the AIDS epidemic after receiving a transfusion of contaminated blood while giving birth to her daughter Ariel. [4] Glaser unknowingly passed the virus to Ariel and to her son Jake, who was born three years later.

The virus went undetected in all three family members until they underwent HIV testing in 1985, at which time Ariel began suffering from a series of unexplained illnesses. Ariel had developed advanced AIDS at a time when the medical community knew very little about the disease, and there were no available treatment options particularly for children. The U.S. Food and Drug Administration approved AZT in 1987 as a drug that could extend the lives of AIDS patients, but this approval only extended to adults. Although the Glasers fought to have their daughter treated with AZT intravenously, Ariel died from complications of AIDS in 1988. [4]

In the aftermath of Ariel's death, and determined to save her son Jake, as well as to give hope to other HIV-positive children, Glaser co-founded the Pediatric AIDS Foundation in 1988 with friends Susan DeLaurentis and Susie Zeegen. Their work raised public awareness about HIV infection in children, and spurred funding for the development of pediatric AIDS drugs as well as research into mother-to-child transmission of HIV. In 1991, Glaser published an autobiography about her family's ordeal. The book was entitled In the Absence of Angels, and it was co-written with author Laura Palmer. [5]

An advocate for the elimination of pediatric AIDS, Glaser became known to audiences nationwide when she was a featured speaker at the 1992 Democratic National Convention. During her speech, she criticized the federal government's underfunding of AIDS research and its lack of initiative in addressing the AIDS crisis. Elizabeth and her family also were profiled in a 1991 edition of People .

Glaser died in 1994, and the Pediatric AIDS Foundation was renamed the Elizabeth Glaser Pediatric AIDS Foundation in her honor shortly thereafter. [4]

1994 - present

As of December 31, 2009, the Foundation reached the following milestones in its prevention, care, and treatment initiatives:

Activities

EGPAF works to eliminate pediatric AIDS in three ways:

Grants and awards

The Elizabeth Glaser Pediatric AIDS Foundation provides several grants and awards to scientists performing research aimed towards the study and eradication of pediatric AIDS.[ citation needed ] The Elizabeth Glaser Scientist Award is one of the many awards that the foundation offers through a competitive award application process.[ citation needed ]

Award and grant winners

  • Margaret Feeney, M.D., M.Sc. 2006 Elizabeth Glaser Scientist Award Winner for her project, "The Immune Response to Acute Perinatal HIV Infection".
  • Alexandra Trkola, Ph.D. 2006 Elizabeth Glaser Scientist Award Winner for her project, "The Humoral Immune Response to HIV".
  • Jeffrey S. A. Stringer, M.D. 2002 Elizabeth Glaser Scientist Award Winner for his project, "Optimal Use of Nevirapine to Prevent Perinatal HIV".
  • Sunil Kumar Ahuja, M.D. 2001 Elizabeth Glaser Scientist Award Winner for work on the influence of genetics on HIV/AIDS. [7]
  • Katherine Luzuriaga, M.D. 1997 Elizabeth Glaser Scientist Award Winner for work on HIV infections within children [8]

Goals

The Foundation’s overarching goals include:

Related Research Articles

<span class="mw-page-title-main">Zidovudine</span> Antiretroviral medication

Zidovudine (ZDV), also known as azidothymidine (AZT), was the first antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use in combination with other antiretrovirals. It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure. It is sold both by itself and together as lamivudine/zidovudine and abacavir/lamivudine/zidovudine. It can be used by mouth or by slow injection into a vein.

<span class="mw-page-title-main">President's Emergency Plan for AIDS Relief</span> United States governmental initiative

The United States President's Emergency Plan For AIDS Relief (PEPFAR) is a United States governmental initiative to address the global HIV/AIDS epidemic and help save the lives of those suffering from the disease. Launched by U.S. President George W. Bush in 2003, as of May 2020, PEPFAR has provided about $90 billion in cumulative funding for HIV/AIDS treatment, prevention, and research since its inception, making it the largest global health program focused on a single disease in history until the COVID-19 pandemic. PEPFAR is implemented by a combination of U.S. government agencies in over 50 countries and overseen by the Global AIDS Coordinator at the United States Department of State. As of 2023, PEPFAR has saved over 25 million lives, primarily in sub-Saharan Africa.

Elizabeth Glaser was an American AIDS activist and child advocate married to actor and director Paul Michael Glaser. She contracted HIV very early in the AIDS epidemic after receiving an HIV-contaminated blood transfusion in 1981 while giving birth. Like other HIV-infected mothers, Glaser unknowingly passed the virus to her infant daughter, Ariel, who died in 1988.

<span class="mw-page-title-main">HIV/AIDS in India</span>

HIV/AIDS in India is an epidemic. The National AIDS Control Organisation (NACO) estimated that 2.14 million people lived with HIV/AIDS in India in 2017. Despite being home to the world's third-largest population of persons with HIV/AIDS, the AIDS prevalence rate in India is lower than that of many other countries. In 2016, India's AIDS prevalence rate stood at approximately 0.30%—the 80th highest in the world. Treatment of HIV/AIDS is via a combination of antiretroviral drugs and education programs to help people avoid infection.

<span class="mw-page-title-main">HIV/AIDS in Mozambique</span>

Mozambique is a country particularly hard-hit by the HIV/AIDS epidemic. According to 2008 UNAIDS estimates, this southeast African nation has the 8th highest HIV rate in the world. With 1,600,000 Mozambicans living with HIV, 990,000 of which are women and children, Mozambique's government realizes that much work must be done to eradicate this infectious disease. To reduce HIV/AIDS within the country, Mozambique has partnered with numerous global organizations to provide its citizens with augmented access to antiretroviral therapy and prevention techniques, such as condom use. A surge toward the treatment and prevention of HIV/AIDS in women and children has additionally aided in Mozambique's aim to fulfill its Millennium Development Goals (MDGs). Nevertheless, HIV/AIDS has made a drastic impact on Mozambique; individual risk behaviors are still greatly influenced by social norms, and much still needs to be done to address the epidemic and provide care and treatment to those in need.

<span class="mw-page-title-main">HIV/AIDS in Zimbabwe</span> Major public health issue

HIV and AIDS is a major public health issue in Zimbabwe. The country is reported to hold one of the largest recorded numbers of cases in Sub-Saharan Africa. According to reports, the virus has been present in the country since roughly 40 years ago. However, evidence suggests that the spread of the virus may have occurred earlier. In recent years, the government has agreed to take action and implement treatment target strategies in order to address the prevalence of cases in the epidemic. Notable progress has been made as increasingly more individuals are being made aware of their HIV/AIDS status, receiving treatment, and reporting high rates of viral suppression. As a result of this, country progress reports show that the epidemic is on the decline and is beginning to reach a plateau. International organizations and the national government have connected this impact to the result of increased condom usage in the population, a reduced number of sexual partners, as well as an increased knowledge and support system through successful implementation of treatment strategies by the government. Vulnerable populations disproportionately impacted by HIV/AIDS in Zimbabwe include women and children, sex workers, and the LGBTQ+ population.

Cases of HIV/AIDS in Peru are considered to have reached the level of a concentrated epidemic.

The first HIV/AIDS case in Malaysia made its debut in 1986. Since then, HIV/AIDS has become one of the country's most serious health and development challenges. As of 2020, the Ministry of Health estimated that 87 per cent of an estimated 92,063 people living with HIV (PLHIV) in Malaysia were aware of their status, 58 per cent of reported PLHIV received antiretroviral therapy, and 85 per cent of those on antiretroviral treatment became virally suppressed. Despite making positive progress, Malaysia still fell short of meeting the global 2020 HIV goals of 90-90-90, with a scorecard of 87-58-85.

Anita Rachlis, M.D. is a Canadian HIV/AIDS researcher and is the principal author of the HIV treatment guidelines in Canada. She is an associate scientist at the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, in Toronto, Ontario, Canada.

Michael Stuart Gottlieb is an American physician and immunologist known for his 1981 identification of acquired immune deficiency syndrome (AIDS) as a new disease, and for his HIV/AIDS research, HIV/AIDS activism, and philanthropic efforts associated with HIV/AIDS treatment.

HIV prevention refers to practices that aim to prevent the spread of the human immunodeficiency virus (HIV). HIV prevention practices may be undertaken by individuals to protect their own health and the health of those in their community, or may be instituted by governments and community-based organizations as public health policies.

Arthur J. Ammann was an American pediatric immunologist and advocate known for his research on HIV transmission, discovering in utero transmission and the risk of contaminated transfusions and blood products, and his role in the development of the first successful vaccine to prevent pneumococcal infection in 1977. He founded Global Strategies for HIV Prevention and was Clinical Professor of Pediatrics at the UCSF Medical Center.

Deborah Persaud is a Guyanese-born American virologist who primarily works on HIV/AIDS at Johns Hopkins Children's Center.

Breastfeeding by HIV-infected mothers is the practice of breastfeeding of HIV-infected mothers and include those who may want to or are currently breastfeeding. HIV can be transmitted to the infant through breastfeeding. The risk of transmission varies and depends on the viral load in the mother's milk. An infant can be infected with HIV throughout the duration of the pregnancy or during childbirth (intrapartum).

<span class="mw-page-title-main">Catholic Medical Mission Board</span>

The Catholic Medical Mission Board (CMMB) is an international, faith-based NGO, providing long-term, co-operative medical and development aid to communities affected by poverty and healthcare issues. It was established in 1912 and officially registered in 1928. CMMB is headquartered in New York City, USA, and currently has country offices in Haiti, Kenya, Peru, South Sudan, and Zambia.

<span class="mw-page-title-main">Janet L. Mitchell</span> American physician

Janet L. Mitchell was an American physician known for her advances in perinatal HIV/AIDS treatment. During the early days of the AIDS epidemic in the U.S. Mitchell developed protocols for health treatment of pregnant women who were HIV positive or at risk for developing AIDS. She advocated against mandatory testing and testifying before Congress, she advocated in favor of an inclusive approach to health care and social services. One of her innovations derived from a study that saw a 70% decrease in HIV transmission to babies when AZT was administered to their mothers during the pregnancy.

<span class="mw-page-title-main">Mark Kline</span> American physician and pediatrician

Mark W. Kline is an American pediatrician and infectious diseases specialist who currently serves as the Physician-in-Chief, Senior Vice President and Chief Medical Officer at Children's Hospital New Orleans and Professor of Pediatrics at the Tulane University School of Medicine and LSU Health New Orleans. Kline is known for his life-long work in building programs for children with HIV/AIDS all over the world.

Etienne Karita is a Rwandan scientist who has been researching HIV/AIDS in Rwanda since the mid-1980s. He has held numerous leadership positions in different organizations that are working to control HIV in Rwanda. Some of his work is concentrated on preventing mother to child transmission of HIV and in collaboration with Projet San Francisco, he has studied HIV in discordant couples.

Josephine Nabukenya is a Ugandan HIV/AIDS activist who is also living with HIV/AIDS. She serves as a Stephen Lewis Foundation Youth program coordinator at Makerere University Johns Hopkins University (MUJHU). She was awarded the Queen’s Young Leader Award in 2016 for her advocacy work. She is also an Ambassador at Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)'s Ariel Club. She is one of the young leaders who grew from being timid to a resilient and powerful young leader who encourages other children to live positively and take their pills.

Catherine Wilfert was an American pediatrician specializing in infectious diseases. She became a professor at Duke University School of Medicine and known internationally for her work in pediatric HIV prevention. After 1993, using zidovudine during pregnancy led to an estimated reduction of mother-to-infant transmission of HIV in the United States by 75 percent and a 47 percent decrease in new HIV infections globally.

References

  1. "Foundation Finder Results". Archived from the original on 2012-07-09. Retrieved 2009-06-20.
  2. 1 2 "Elizabeth Glaser Pediatric AIDS Foundation" (PDF). Foundation Center. Retrieved 2 January 2018.
  3. "Elizabeth Glaser Pediatric AIDS Foundation". Elizabeth Glaser Pediatric AIDS Foundation. Retrieved 2023-11-15.
  4. 1 2 3 4 "Elizabeth's Story - Elizabeth Glaser Pediatric AIDS Foundation". Elizabeth Glaser Pediatric AIDS Foundation. Retrieved 2023-11-15.
  5. Kevles, Bettyann (1991-03-03). "The Youngest Victims of AIDS". New York Times.
  6. "Elizabeth Glaser Pediatric AIDS Foundation 2009 Annual Report". Elizabeth Glaser Pediatric AIDS Foundation. Archived from the original on 2011-07-28.{{cite web}}: CS1 maint: unfit URL (link)
  7. "HSC investigator earns Elizabeth Glaser Scientist Award". UTHSCSA News. 2001-01-12. Archived from the original on 2004-06-17. Retrieved 2008-04-11.
  8. "Notable Asian/Pacific American Physicians in U.S. History". American Board of Internal Medicine. 18 May 2017. Retrieved 1 May 2023.